Search results
Sanofi Sales, Profit Beat Expectations
The Wall Street Journal· 7 days agoSanofi backed its full-year earnings guidance after it reported first-quarter profit ahead of consensus, with sales growth driven by continued strength...
Sanofi (NASDAQ:SNY) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoSanofi (NASDAQ:SNY) Q1 2024 Earnings Call Transcript April 25, 2024 Sanofi reports earnings inline with expectations. Reported EPS is $0.96 EPS,...
Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up
Zacks via Yahoo Finance· 7 days agoBiopharma sales rose 6.3% in the quarter to €8.94 billion. Pharma sales increased 6.4% to €7.76...
Should You Consider Regeneron (REGN) Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 2 days agoAn increase in profits from Dupixent and further uptake of Eylea HD are likely to have aided...
Board trying to lower drug costs urges Marylanders to help ‘fill in’ info gaps
Maryland Matters via Yahoo News· 2 days agoThe Prescription Drug Affordability Board is seeking feedback from patients, physicians and manufactures to provide context and first-hand experience about trying to afford medications for certain ...
Sanofi jumps as Q1 key profit measure tops estimates; Citi reiterates Buy
Investing.com· 7 days agoSanofi jumps as Q1 key profit measure tops estimates; Citi reiterates Buy
What to Watch in the Day Ahead - Thursday, May 2
Reuters via Yahoo Finance· 10 hours agoInvestors will expect commentary on how it plans to revive sales and updates on AI development, which is driving gains at Big Tech peers. Moderna is expected report first-quarter earnings, as ...
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Zacks via Yahoo Finance· 6 days agoMerck slightly raised the upper end of its 2024 revenue guidance range from $62.7-$64.2 billion to...
The Zacks Analyst Blog Highlights Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday...
Zacks via Yahoo Finance· 7 days agoSince 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year....
Unable to work since COVID vaccination, Gatineau man pins hopes on compensation
CBC via Yahoo News· 3 days agoA Gatineau, Que., man who developed a debilitating skin ailment after receiving a COVID-19 vaccine...
